| ACCUTANE
Jack’s law firm
is evaluating Accutane cases where any of the following
injuries have occurred.
- Suicidal Behavior
- Birth Defects
- Ulcerative Colitis
- Crohn's Disease
- Inflammatory
Bowel Disorder
- Rectal Bleeding
- Abdominal Pain
- Central Nervous
System Injuries
- Bone and Muscle
Loss
- Cardiovascular
Injuries
- Liver and Kidney
Damage
- Pancreatitis
- Immune System
Disorder
- Lupus
- Hearing and Vision
Damage
- Thyroid Disorders
In 1998, the Food and
Drug Administration advised doctors who prescribe Accutane
to watch their patients for signs of depression. Afterward,
the Hoffman-LaRoche, the maker of Accutane, notified
doctors that the drug ``may cause depression, psychosis,
and, rarely, suicidal ideation, suicide attempts and
suicide.''
However, the knowledge
of the potential danger associated with Accutane did
not become widely known until a Congressman's son committed
suicide. Rep. Bart Stupak says his 17 year old son's
suicide in 2003 may be linked to the popular acne medicine.
Bart Stupak Jr., known as "B.J.," shot himself
in the head with his father's gun in the early hours
of May 14. Stupak was popular in school, a football
player, and killed himself after a prom-night party.
In assessing how many
potential suicide cases could be linked to Accutane,
Rep. Stupak stated, "We are up over 100 reports,
that's just what is coming in to us, so I believe there
are probably over a thousand cases," Stupak said.
"The average time is 88 days from when you start
taking it, and the effect is very sudden.... You are
doing strange things at 3 a.m. and you are dead at 7
a.m."
The FDA has received reports
of 66 suicides and 1,373 cases of psychiatric problems
among Accutane users as of early December, 2000 according
to a report in USA Today. Accutane's package warning
first stated potential relationship between Accutane
and depression in 1986. Although French officials required
that Hoffman-LaRoche add the risk of suicide to the
package insert of the European version of Accutane in
March 1997, the FDA did not require such a change in
the USA until 1999.The FDA has received reports of 66
suicides and 1,373 cases of psychiatric problems among
Accutane users as of early December, 2000 according
to a report in USA Today. Accutane's package warning
first stated potential relationship between Accutane
and depression in 1986. Although French officials required
that Hoffman-LaRoche add the risk of suicide to the
package insert of the European version of Accutane in
March 1997, the FDA did not require such a change in
the USA until 1999.
In
early 2001, the FDA announced that new warning labels
and consent forms would be required for Accutane. The
new consent forms will urge patients to watch for signs
of depression, such as feelings of sadness, irritability,
unusual tiredness or appetite loss.
If
you believe that you may have had a bad experience with
Accutane, call us Now for a FREE Consultation.
|
